A Phase-3 multi centre, randomized, parallel, double blind, placebo control, clinical study to determine the efficacy and safety of Betadine Nasal spray Povidone Iodine IP 0.5% w/v for the treatment of Rhinitis in patients suffering from Rhinitis associated with Upper respiratory tract infection along with standard care of therapy. - NIL
100 项与 G.S. Pharmbutor Pvt Ltd. 相关的临床结果
0 项与 G.S. Pharmbutor Pvt Ltd. 相关的专利(医药)
100 项与 G.S. Pharmbutor Pvt Ltd. 相关的药物交易
100 项与 G.S. Pharmbutor Pvt Ltd. 相关的转化医学